Public Board of Directors papers 29.09.22

We continue to report cases of a range of infections although other than for C Difficile there are no national standards or thresholds. Although we continue to have patients with C Difficile, reflecting community prevalence of infection and the vulnerability of our patients, audits show that in no case has infection been the result of a lapse in the standards of care. Whilst the number of formal complaints was comparable to previous months, the number of contacts with the Patient Advice and Liaison Service (PALS) increased from 36 in July to 66 in August. Most of the increase was in PALS contacts to provide compliments. Our post treatment mortality rates remain within the expected very low limits.

See details in Integrated Performance, Quality and Finance Report Responsible Executive Directors - Chief Nurse and Medical Director Responsible assurance committee – Quality Assurance

Workforce Our summary workforce performance indicators continue to show overall good performance with improvements in our essential training and personal development plan rates over the most recent quarter to 85.5% and 86.4% respectively. Sickness absence is high (4.43% against an upper acceptable limit of 3.4%) and the annual adjusted turnover rate is at 16.78%. These issues and the associated plans for improvement have been considered by the new Workforce Assurance Committee. Work is continuing to refresh the Trust’s approach to values and behaviours. Over the summer, focus groups and other engagement events have been held with a range of staff giving them the opportunity help shape the new approach. Since the most recent report four new consultant appointments have been recommended by properly constituted advisory appointments committees each chaired by a non-executive director. The board is asked to note the following recommended appointments based on the appointment committee advice: • Dr Catherine Blake - Consultant Clinical Oncology with an interest in Breast Cancer and Acute Oncology. • Dr Danya Abulwahid - Consultant in Clinical Oncology with an interest in Lung Cancers. • Dr Jenny King - Consultant in Clinical Oncology with and interest in Lung and CNS Cancers • Dr Claire Barker - Consultant in Clinical Oncology with and interest in Lung and CNS Cancers. In addition, two senior nurse/allied health professional appointments have been made and which the board is asked to note: • David Wright - Associate Chief Nurse, Patient Experience (a newly developed role) • Caroline Rogers - Associate Chief Nurse, Network Services (a newly developed role) Divisions are planning for the potential for industrial action relating to the National Pay Award over the autumn/winter period. The Trust has received notification from the RCN of its intention to ballot

its members and notifications from other Trade unions are likely to follow. See details in Integrated Performance, Quality and Finance Report Responsible Director - Director of Workforce Responsible Assurance Committee – Workforce Assurance Committee

28